TCPS CEO meeting with Council yesterday, next

New Post Public Reply Private Reply Replies (1) Message Board

May 30, 2013 at 9:11 AM

TCPS CEO meeting with Council yesterday, next filings/news..... Hole lot of DD here to browse.....

TCPS is clearly undervalued, with mrkt cap under 2mil and $50-100mil in active patents with 75mil of NOLS, recent revival means things are back on track....

TCPS MVNO Technology HUGE Market

TCPS was at $150M market cap in 2007 with a 55M O/S with liquidity, currently market ca right at 1mil.It was trading a million shares a day at $2.50. The main genius is Hickling. It now has a 78M O/S, and IMO, this reorganization will keep it under 100M O/S. The regeneration of interest in the tech mixed with a possible Hickling Apr 2013 patent mixed in...well you know my thoughts.

Please read, and all read, the stickies. Take 5 and learn about what an MVNO is and how dominate they are in the cell phone landscape. Then, consider how TCPS is likely to aim at offering these MVNO's circuitry that allows phones to switch carriers/networks without reprogramming and replacing SIM cards. It's insanity and possibly, just might be, worth the B$ wo.

Ok I spoke to Anthony, WE STRUCK GOLD HERE here are the key parts:

1. Pignatello wants tcps because of its extremely valuable patents and tcps owns valuable shell assets as well!!!

2. we will remaim in pinks for now but he plans on higher exchange due to the fact that TCPS is very very valuable and he does not want it trading in pinks...wants an exchange upgrade.

3. Plans on full disclosure before the end of next week..

4. is meeting tomorrow with the former council of TCPS tomorrow(my guess to finalize the deal between them).

5. There will be sizeable changes made here with TCPS

odiaz28 Member Profile odiaz28 Member Level

Tuesday, May 28, 2013 1:31:26 PM
Re: GEM post# 3498
Post # of 3967

TCPS Buy out Very Possible, What is Pignatello a specialist with.... not hard to connect the dots....

My instinct says he wants the Telcom patents here and match it with his recent http://www.dibara.com/mvmo.html

TCPS TechnoConcepts, Inc. doing business as Terocelo Inc., together with its subsidiaries, engages in the design, development, manufacture, and marketing of wireless communications semiconductors in the United States. It manufactures wireless transmitter and receiver microchips based on its proprietary technology, True Software Radio. The True Software Radio enables communications devices, such as cell phones, PDAs, laptops, and other mobile devices to communicate with other communications devices across various wireless standards, such as CDMA, TDMA, GSM, GPRS, G3, Bluetooth, WiFi, WiMAX, and WiBro. The company also designs and sells products for Internet television, stream media protocol proces

http://investorshub.advfn.com/boards/read_msg...d=88235467

http://investorshub.advfn.com/boards/read_msg...d=88235430

From 2001 to 2006, Mr. Pignatello managed Global Phoneworks, LLC, a mobile virtual network operator in McLean, Virginia, growing revenues by over 200% over a 5 year period and increasing network capacities to reduce fixed costs, increasing gross profit by over 40%.

Mr. Pignatello is also a partner in DIBARA, Inc., a full service MVNO offering its corporate clients customized telecommunications services

Details of of 8 Patents
1) 7236112 Self-tuning output digital filter for direct conversion delta-sigma transmitter -06/26/2007
2) 5563598 Differential comparator cirucit 10/08/1996
3)20060164273 -Self-tuning output digital filter for direct conversion delta-sigma transmitter filed 01/20/2006
4)6748025 Directconversion delta-sigma receiver-06/08/2004
5)20080042742 Distortion Nulling for Single-Ended High Dynamic Range RF Amplifier filed 08/15/2007
6)20060115005 -Direct conversion delta-sigma transmitter
filed 11/26/2004
7)20070082638 -Adaptive Narrowband Interference Canceller for Broadband Systems filed 08/30/2006
8)20060164167 Linear commutating amplifier filed 09/02/2005

Link http://www.archpatent.com/search -it shows 10 patents ,disregard first two.

Fact is Hickling is the Founder of TCPS and holds 25% of the company via Preferred A and also has 2M common shares via Fiber Optic Techno so I'd say this Apr 2013 patent was the genesis of this new chapter.

http://www.otcmarkets.com/edgar/GetFilingHtml...ID=5239528

http://www.corporationwiki.com/California/San...11102.aspx

Holy chit

We will find out much more soon.

IMO here's the scoop....

Pignatello who is currently working with http://www.dibara.com/mvmo.html is getting his group into TCPS for their existing software patent that allows users of cell phones to switch networks/carriers without having to buy a new cell phone. This is for the MVNO market (Tracphone among 600 others world wide http://www.prepaidmvno.com/ ). Believe it or not, about 50% of the world is on prepaid cell phones.

Example, I go into Walmart and buy a phone to use with Tracphone, 2 months later I see a better deal and want to switch, but that MVNO is on a different network and I have to buy another phone. Well, TCPS via Dibara will allow MVNO's to use their software such that the user only has to get their Dibara chip reset remotely. No need to buy another phone to switch between prepaid companies.

MVNO's are hot, and only getting hotter. http://en.wikipedia.org/wiki/Mobile_virtual_network_operator

If I'm correct on this, it's a grand slam the likes I haven't seen down here.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...